FIELD: medicine, phthisiology.
SUBSTANCE: method involves inhalation administration of kanamycin dissolved in silver nitrate ammonium solution followed by irradiation by laser radiation from the semiconductive device "Uzor" along paravertebral zone with wavelength 0.89 mcm, power 4 Wt, impulse frequency 80 Hz and general exposition for 256 s. Method provides accelerating periods for ceasing secretion of polyresistant populations of Mycobacterium tuberculosis and the secondary non-specific microflora in patients with destructive pulmonary tuberculosis with concomitant suppurative bronchitis.
EFFECT: enhanced effectiveness of treatment.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DESTRUCTIVE PULMONARY TUBERCULOSIS | 2010 |
|
RU2450820C2 |
| PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
| METHOD OF TREATMENT OF NON-SPECIFIC ENDOBRONCHITIS IN PATIENT WITH DESTRUCTIVE PULMONARY TUBERCULOSIS | 0 |
|
SU1804854A1 |
| METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS WITH ACCOMPANYING NON-SPECIFIC BRONCHITES | 2013 |
|
RU2526121C1 |
| METHOD OF TREATING PLEURAL EMPYEMA | 2017 |
|
RU2661090C1 |
| METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS MULTIPLE DRUG-RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2018 |
|
RU2687743C1 |
| METHOD OF TREATING BRONCHIAL TUBERCULOSIS IN PATIENTS WITH LUNG TUBERCULOSIS WITH A MULTIDRUG RESISTANCE / EXTENSIVELY DRUG RESISTANCE OF DISEASE CAUSATIVE AGENT | 2019 |
|
RU2727760C1 |
| METHOD OF MYCOBACTERIUM TUBERCULOSIS EXPOSING IN VITRO EXPERIMENT | 2017 |
|
RU2675692C1 |
| METHOD FOR TREATING PATIENTS FOR PULMONARY TUBERCULOSIS ACCOMPANIED WITH PURULENT ENDOBRONCHITIS | 2004 |
|
RU2262938C1 |
| METHOD FOR TREATING DESTRUCTIVE PULMONARY TUBERCULOSIS | 2006 |
|
RU2312616C1 |
